Pacific RxTracts - July 2025

Authors

Pacific RxTracts

Files

Description

Articles:

• First Blood Test Approved For the Diagnosis of Alzheimer’s Disease
• Rare Withdrawal Reaction Prompts Label Update for Common Antihistamines
• FDA Approves SUSVIMO: Shifting Diabetic Retinopathy Treatment from Monthly Injections to Continuous Therapy
• Battle Against Resistant Hypertension
• Two Is Better than One: Obicetrapib and Ezetimibe, a Novel Combination Pill for High Cholesterol
• Histo-blood Group ABO System Transferase and Venous Thromboembolism Risk
• GLP-1 Agonists and Thiazolidinedione Combination Therapy in Type 2 Diabetes
• Dual Pathway Targeting in Type 2 Diabetes: Exploring the Synergy of GLP1- RAs and SGLT2-inhibitors
• Two Vaccines, One Shot: Combined Immunizations Against COVID-19 and Influenza
• Mirikizumab: A New Frontier in Ulcerative Colitis Treatment
• Tocilizumab: A Better Way to Manage Rheumatoid Arthritis
• Oveporexton: A Novel Treatment Option for Narcolepsy Type I
• The Long-Term Effects of Ketamine on Treatment- Resistant Depression
• The First Targeted Therapy for a Rare Ovarian Cancer
• Vimseltinib Gains FDA Approval for Tenosynovial Giant Cell Tumour (TGCT)
• Hot Flashes No More
• Remote Clinical Pharmacists Drive Down Cancer Care Costs in Value-Based Model
• Camizestrant Takes Victory Lap After Phase 3 Trials

Publication Date

7-3-2025

Volume

22

Issue

8

Pages

9

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - July 2025" (2025). Pacific RxTracts. 8.
https://scholarlycommons.pacific.edu/rx-tracts/8